Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
302 participants
INTERVENTIONAL
2021-04-01
2023-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
NCT06835491
PROSPECTIVE ANALYSIS BETWEEN AMIODARONE Versus LIDOCAINE IN SVT
NCT03299517
Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
NCT01401647
To Determine Optimal Time for Delivering Electrical Shocks to Cardiac Arrest Patients
NCT01665755
Time-dependent Amiodarone Treatment in Atrial Fibrillation
NCT03432663
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
However until now there has not been any evidence of prophylactic anti arrhythmic drug effect during post cardiac arrest care.
Amiodarone is class III anti arrhythmic drug which has been used for conversion of ventricular arrhythmia during CPR.
In this study we want to determine whether the prophylactic amiodarone can prevent re-arrest with ventricular shockable rhythm or not.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Prophylactic amiodarone
Amiodarone Injection
Amiodarone continuous infusion during 24 hours from return of spontaneous circulation.
Conventional management
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Amiodarone Injection
Amiodarone continuous infusion during 24 hours from return of spontaneous circulation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* pregnancy
* non cardiac caused arrest such as hanging
* previous amiodarone continuous infusion before radomization
* sustained ventricular arrhythmia recurrence after ROSC
* extracorporeal membrane oxygenation
* contra indication for amiodarone
* disagree with this research
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Won Young Kim
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Won Young Kim
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical Center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PASCA trial
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.